Witz joins Global Alzheimer’s Platform Foundation board
In this new position, Witz will offer counsel using her previous work experience as a health care executive in charge of top health care companies. Her three-year term began on Sept. 1.
"It's an honor and a pleasure to have been invited to join the GAP board of directors," Witz said. "During my career, I have been involved in a number of efforts to better understand and address the challenge presented by Alzheimer's disease, particularly in its early stages. The opportunity to take on a greater role in this cause was one I eagerly embraced. I am excited to join the GAP team and my fellow board members."
The board anticipates the benefits of Witz’s previous experience in the health industry.
"We are delighted to add such an experienced health care executive to our board," George Vradenburg, board chairman of GAP, said. "Pascale has held both pharma and non-pharma roles during her extensive career. This broad experience will be a huge asset to the GAP board. We look forward to continuing to accelerate the Alzheimer's clinical trial process with Pascale's strategic guidance."
With Witz, the organization looks forward to making more progress with its clinical trials against Alzheimer’s.
"Pascale will significantly enhance our efforts to bring innovation and creative solutions to the clinical trial process," John Dwyer, president of GAP, said. "Her strategic vision and experience with change management at Sanofi and GE will greatly inform our efforts to optimize AD clinical trials."
Organizations in this story
Global Alzheimer's Platform Foundation, Inc. 1101 K St NW Washington, DC 20005